Julio Cesar Cetrulo Lorenzi
Julio Cesar Cetrulo Lorenzi
Principal Scientist
Verified email at - Homepage
Cited by
Cited by
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ...
Nature 584 (7821), 437-442, 2020
Evolution of antibody immunity to SARS-CoV-2
C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ...
Nature 591 (7851), 639-644, 2021
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ...
elife 9, e61312, 2020
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
M Caskey, F Klein, JCC Lorenzi, MS Seaman, AP West Jr, N Buckley, ...
Nature 522 (7557), 487-491, 2015
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies
CO Barnes, AP West, KE Huey-Tubman, MAG Hoffmann, NG Sharaf, ...
Cell 182 (4), 828-842. e16, 2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ...
Journal of Experimental Medicine 217 (11), e20201181, 2020
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
JF Scheid, JA Horwitz, Y Bar-On, EF Kreider, CL Lu, JCC Lorenzi, ...
Nature 535 (7613), 556-560, 2016
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
P Mendoza, H Gruell, L Nogueira, JA Pai, AL Butler, K Millard, ...
Nature 561 (7724), 479-484, 2018
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Z Wang, JCC Lorenzi, F Muecksch, S Finkin, C Viant, C Gaebler, ...
Science translational medicine 13 (577), eabf1555, 2021
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
M Shingai, OK Donau, RJ Plishka, A Buckler-White, JR Mascola, ...
Journal of Experimental Medicine 211 (10), 2061-2074, 2014
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
T Schoofs, F Klein, M Braunschweig, EF Kreider, A Feldmann, L Nogueira, ...
Science 352 (6288), 997-1001, 2016
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ...
Journal of Experimental Medicine 218 (3), e20201993, 2020
Longitudinal serological analysis and neutralizing antibody levels in coronavirus disease 2019 convalescent patients
F Muecksch, H Wise, B Batchelor, M Squires, E Semple, C Richardson, ...
The Journal of infectious diseases 223 (3), 389-398, 2021
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ...
Immunity 54 (8), 1853-1868. e7, 2021
Planejamento, montagem e aplicação de modelos didáticos para abordagem de biologia celular e molecular no ensino médio por graduandos de ciências biológicas
TC Orlando, AR Lima, AM da Silva, CN Fuzissaki, CL Ramos, D Machado, ...
Revista de Ensino de Bioquímica 7 (1), 1-17, 2009
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
JCC Lorenzi, YZ Cohen, LB Cohn, EF Kreider, JP Barton, GH Learn, ...
Proceedings of the National Academy of Sciences 113 (49), E7908-E7916, 2016
Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis
J Lorenzi, A Trombone, C Rocha, L Almeida, R Lousada, T Malardo, ...
BMC biotechnology 10 (1), 77, 2010
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller
Science Translational Medicine 9 (373), eaal2144, 2017
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
J Xu, K Xu, S Jung, A Conte, J Lieberman, F Muecksch, JCC Lorenzi, ...
Nature 595 (7866), 278-282, 2021
Non-neutralizing antibodies alter the course of HIV-1 infection in vivo
JA Horwitz, Y Bar-On, CL Lu, D Fera, AAK Lockhart, JCC Lorenzi, ...
Cell 170 (4), 637-648. e10, 2017
The system can't perform the operation now. Try again later.
Articles 1–20